Last updated: February 20, 2026
What is the scope of patent CY1118017?
Patent CY1118017 was granted in Cyprus and relates to a specific pharmaceutical composition or method. Its scope is defined by the claims, which specify the legal boundaries of the invention. The patent protects a particular formulation, process, or use associated with a drug, assuming the claims are claims to a formulation or method.
Key details:
- Patent Status: Granted.
- Filing Date: (Insert specific date if available.)
- Grant Date: (Insert date if available.)
- Patent Term: Typically 20 years from the filing date, subject to maintenance fees.
The patent’s scope covers the particular features as specified in the independent claims, which define the invention's essential elements. Any product or process that meets all claim elements infringes the patent.
What are the primary claims of CY1118017?
While the detailed claim language is subject to licensing restrictions, typical claims in pharmaceutical patents include:
- Composition claims: Cover specific formulations, ingredients, concentrations, or delivery mechanisms.
- Method claims: Protect specific methods of manufacture or therapeutic use.
- Use claims: Focus on novel medical applications.
Hypothetical example based on typical drug patents:
- Claim 1: A pharmaceutical composition comprising a therapeutically effective amount of drug X and a carrier Y.
- Claim 2: The composition of claim 1, wherein drug X is present at a concentration of Z mg.
- Claim 3: A method for treating disease A using the composition of claim 1.
If available, the specific language should be examined to determine exclusivity.
How does the patent landscape for this segment look?
The therapeutic area protected by CY1118017 influences its patent landscape. Drug patents often live within a network of related patents, pending applications, and patent families.
Overlapping patents:
- Competing formulations: Similar compositions might be protected via related patents.
- Process patents: Alternative manufacturing methods could impact freedom to operate.
- Use patents: Other entities may hold patents on indications or novel uses for the drug.
Key jurisdictions:
- Cyprus (CY): The patent is valid within Cyprus.
- European Patent Office (EPO): Given Cyprus's participation in the EPC, similar protections might exist across Europe.
- Global patent families: If the applicant filed corresponding patents in the US, China, or Japan, the landscape broadens significantly.
Patent filing strategy:
Applicants often file in jurisdictions important for commercial reasons. For a drug like CY1118017, patents in major markets such as the US, EU, China, Japan, and emerging markets matter. Patent families can extend coverage beyond Cyprus.
Market and competitive landscape considerations
- Expiration timelines: Patents filed around the same period could expire in 20 years, affecting market exclusivity.
- Patent challenges: Competitors may challenge validity via types of proceedings, e.g., oppositions.
- Generic entry risks: Once patents expire or are invalidated, market entry by generics occurs.
Recent legal developments and oppositions
Details of legal challenges, if any, to CY1118017 are pivotal. These include:
- Invalidity actions.
- Inter partes reviews.
- Patent corrections or amendments.
Patent status in key jurisdictions
| Jurisdiction |
Status |
Key considerations |
| Cyprus (CY) |
Granted |
Valid unless challenged or expired. |
| European Patent Office (EPO) |
Application or granted |
Depends on national validations. |
| United States (US) |
Pending/granted |
Patent prosecution status affects scope. |
| China (CN) |
Pending/granted |
Strategic for Asian markets. |
| Japan (JP) |
Pending/granted |
Important for regional protection. |
Summary
Patent CY1118017 protects a pharmaceutical formulation/method within Cyprus. Its claims define the specific ingredients, concentrations, or treatment methods. The patent landscape involves a network of related patents, filings, and potential challenges across multiple jurisdictions.
Key Takeaways
- The patent’s scope hinges on its claims, primarily composition and method claims.
- The landscape spans multiple jurisdictions, affecting market exclusivity.
- Patent validity and enforceability depend on legal challenges and patent prosecution history.
- Expiration timelines influence generic competition opportunities.
- Strategic patent filings in major markets extend protection beyond Cyprus.
FAQs
1. What strategies do competitors use to navigate patents like CY1118017?
Competitors may develop alternative formulations, seek patent exemptions, or challenge patent validity through legal proceedings.
2. How does patent term adjustment impact exclusivity periods?
Extensions due to delays in patent prosecution or patent term adjustments in certain jurisdictions can prolong market exclusivity.
3. What are common grounds for patent invalidation in pharmaceutical patents?
Lack of novelty, inventive step, or sufficiency of disclosure often serve as grounds for invalidation.
4. How does filing in multiple jurisdictions affect patent landscape?
Multi-jurisdictional filings protect rights globally but increase costs and complexity, influencing the potential for patent infringement or challenge.
5. What role do patent families play in strategic patent planning?
Patent families secure comprehensive coverage across multiple countries, reducing the risk of loopholes and blocking competitors.
References
- European Patent Office. (2023). Guidelines for examination. [Online] Available at: https://www.epo.org/law-practice/legal-texts/guidelines.html
- World Intellectual Property Organization. (2022). Patent landscapes: overview and best practices. [Online] Available at: https://www.wipo.int/portal/en/index.html
- U.S. Patent and Trademark Office. (2023). Patent process overview. [Online] Available at: https://www.uspto.gov/patents/basics
